The present study evaluated the prevalence and therapy of deep vein thrombosis (DVT) after total hip arthroplasty (THA) and total knee arthroplasty (TKA) in 57 patients with previous ischemic stroke. Postoperative anticoagulants were used for DVT prophylaxis, and batroxobin and prolonged anticoagulants were used for thrombolysis in DVT subjects. The incidence of DVT after THA and TKA in patients with previous ischemic stroke was 16.2% and 20%, respectively. No bleeding complications were observed and no new ischemic stroke occurred during the following 3 months. The prevalence DVT after THA and TKA in patients with previous ischemic stroke was not specific, and the treatment of DVT with batroxobin and anticoagulants was effective and safe.
CohenSHEhrlichGEKauffmanMSCopeC. Thrombophlebitis following knee surgery. J Bone Joint Surg Am. 1973;55:106-112.
2.
StulbergBNInsallJNWilliamsGWGhelmanB. Deep-vein thrombosis following total knee replacement: an analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am. 1984;66:194-201.
3.
LynchAFBourneRBRorabeckCHRankinRNDonaldA. Deep vein thrombosis and continuous passive motion after total knee arthroplasty. J Bone Joint Surg Am. 1988;70:11-14.
4.
TurpieAGGLevineMNHirshJ. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986;315:925-929.
5.
HullRDRaskobGEGentM. Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA. 1990;263:2313-2317.
6.
HoekJANurmohamedMTHamelynckKJ. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid. Thromb Haemost. 1992;67:28-32.
7.
WarlowCOgstonDDouglasAS. Deep venous thrombosis of the legs after strokes. Part I—incidence and predisposing factors. Br Med J. 1976;1:1178-1181.
8.
HarveyRL. Prevention of venous thromboembolism after stroke. Top Stroke Rehabil. 2003;10(3):61-69.
9.
KellyJRuddALewisRRCoshallCMoodyAHuntBJ. Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke. 2004;35:2320-2325.
10.
MulleyGP. Avoidable complications of stroke. J R Coll Physicians Lond. 1982;16:94-97.
11.
NoelPGregoireFCaponALehertP. Atrial fibrillation as a risk factor for deep venous thrombosis and pulmonary emboli in stroke patients. Stroke. 1991;22:760-762.
12.
LandiGD’AngeloABoccardiE. Venous thromboembolism in acute stroke. Prognostic importance of hypercoagulability. Arch Neurol. 1992;49:279-283.
13.
GeertsWHHeitJAClagettGP. Prevention of venous thromboembolism. Chest. 2001;119(1 suppl):132S-175S.
BathPMIddendenRBathFJ. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials. Stroke. 2000;31:1770-1778.
16.
RabinovKPaulinS. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg. 1972;104:134-144.
17.
XingKHMorrisonGLimWDouketisJOdueyungboACrowtherM. Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials. Thromb Res. 2008;123:24-34.
18.
FitzgeraldRHJrSpiroTETrowbridgeAA. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Joint Surg Am. 2001;83:900-906.
19.
LeclercJRGeertsWHDesjardinsL. Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin. Ann Intern Med. 1996;124:619-626.
20.
HullRRaskobGPineoG. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med. 1993;329:1370-1376.
21.
FellerJAParkinJDPhillipsGWHannonPJHennessyOHugginsRM. Prophylaxis against venous thrombosis after total hip arthroplasty. Aust N Z J Surg. 1992;62:606-610.
22.
KimYHKimJS. The 2007 John Charnley Award. Factors leading to low prevalence of DVT and pulmonary embolism after THA: analysis of genetic and prothrombotic factors. Clin Orthop Relat Res. 2007;465:33-39.
23.
KlatskyALArmstrongMAPoggiJ. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000;85:1334-1337.
24.
WestrichGHWekslerBBGlueckCJBlumenthalBFSalvatiEA. Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: an analysis of genetic factors. J Bone Joint Surg Am. 2002;84:2161-2167.
25.
ReesDCCoxMCleggJB. World distribution of factor V Leiden. Lancet. 1995;346:1133-1134.
26.
ChinPLAminMSYangKYYeoSJLoNN. Thromboembolic prophylaxis for total knee arthroplasty in Asian patients: a randomized controlled trial. J Orthop Surg (Hong Kong). 2009;17:1-5.
27.
SutherlandCJSchurmanJR. Complications associated with warfarin prophylaxis in total knee arthroplasty. Clin Orthop Relat Res. 1987;(219):158.
28.
TomaruTUchidaYNakamuraFSonokiHTsukamotoMSugimotoT. Enhancement of arterial thrombolysis with native tissue type plasminogen activator by pretreatment with heparin or batroxobin: an angioscopic study. Am Heart J. 1989;117:275-281.
29.
LatalloZS. Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes—a multicentre trial. Thromb Haemost. 1983;50:604-609.
